However, obese frailty resulted in a significant decrease in LAMP-2 expression [101], suggesting that it may regulate LAMP-2 through mechanisms affecting Smad2/3, FoxO3a, and P62 due to the combined effects of frailty syndromes and obesity. Here, SMAD2 is linked to obesity due to melanocortin 4 receptor deficiency.